Organization | Helen Keller International

Helen Keller International Report issue

Academic/Hospital Phase 1 Phase 4

Founded: New York NY United States (1915)

Organization Overview

First Clinical Trial

2009

NCT00944398

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Helen Keller International

Active Ingredients

Drugs in Phase 4 Trials (5)

azithromycin (zithromax) (2 trials)

cellulose (1 trial)

ferrous bisglycinate (1 trial)

ferrous sulfate (1 trial)

zinc (4 trials)

Drugs in Phase 1 Trials (1)

thiamine (2 trials)

Drugs in Other Trials (8)

beta carotene (solatene) (1 trial)

cow milk (1 trial)

iodine (1 trial)

soybean (1 trial)

vitamin a (1 trial)

zinc dichloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Diarrhea (Phase 4)

Inflammation (Phase 4)

Malaria (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 13
# of Trial APIs: 14